Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
57.65
+2.03 (3.65%)
Sep 16, 2025, 1:22 PM EDT - Market open

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $248.69 billion as of September 16, 2025. Its market cap has decreased by -59.21% in one year.

Market Cap
248.69B
Enterprise Value
261.35B
1-Year Change
-59.21%
Ranking
Category
Stock Price
$57.65

Market Cap Chart

Since December 1, 1998, Novo Nordisk's market cap has increased from $5.15B to $248.69B, an increase of 4,724.39%. That is a compound annual growth rate of 15.56%.

History

DateMarket Cap% Change
Sep 12, 2025244.99B-36.85%
Dec 31, 2024387.95B-17.76%
Dec 29, 2023471.73B54.12%
Dec 30, 2022306.08B19.24%
Dec 31, 2021256.69B55.86%
Dec 31, 2020164.70B16.14%
Dec 31, 2019141.81B23.12%
Dec 31, 2018115.18B-15.84%
Dec 29, 2017136.86B46.79%
Dec 30, 201693.24B-38.18%
Dec 31, 2015150.82B29.59%
Dec 31, 2014116.38B12.48%
Dec 31, 2013103.47B9.30%
Dec 31, 201294.66B36.88%
Dec 30, 201169.16B-0.91%
Dec 31, 201069.79B72.41%
Dec 31, 200940.48B26.82%
Dec 31, 200831.92B-22.43%
Dec 31, 200741.15B52.03%
Dec 29, 200627.07B44.82%
Dec 30, 200518.69B1.87%
Dec 31, 200418.35B29.73%
Dec 31, 200314.14B41.73%
Dec 31, 20029.98B25.01%
Dec 29, 20007.98B36.89%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company671.68B
Johnson & Johnson427.24B
AbbVie384.42B
UnitedHealth Group315.07B
AstraZeneca240.71B
Novartis AG238.00B
Abbott Laboratories228.57B
Merck & Co.202.37B
Market Cap Rankings